Bioscience Animal Health Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 5/6

Bioscience Animal Health yıllık ortalama 0.8% oranında kazançlarını artırırken, Healthcare sektöründe kazançlar growing at 11.8% annual. Gelirler growing yılda ortalama 7.3% oranında artmaktadır. Bioscience Animal Health'in özkaynak karlılığı 8.8% ve net marjı 2.6%'dir.

Anahtar bilgiler

0.8%

Kazanç büyüme oranı

-14.2%

EPS büyüme oranı

Healthcare Sektör Büyümesi	23.6%
Gelir büyüme oranı	7.3%
Özkaynak getirisi	8.8%
Net Marj	2.6%
Son Kazanç Güncellemesi	30 Sep 2024

Yakın geçmiş performans güncellemeleri

Recent updates

Gelir ve Gider Dağılımı

Bioscience Animal Health nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.

Kazanç ve Gelir Geçmişi

SET:BIS Gelir, gider ve kazançlar (THB Millions )
Tarih	Gelir	Kazançlar	G+A Giderleri
30 Sep 24	2,393	63	285
30 Jun 24	2,487	62	282
31 Mar 24	2,464	58	284
31 Dec 23	2,426	51	279
30 Sep 23	2,346	48	264
30 Jun 23	2,287	45	265
31 Mar 23	2,215	45	262
31 Dec 22	2,213	56	260
30 Sep 22	2,181	60	275
30 Jun 22	2,095	66	271
31 Mar 22	2,091	77	268
31 Dec 21	1,986	72	262
30 Sep 21	1,911	75	250
31 Dec 20	1,782	62	262
31 Dec 19	1,881	30	245

Kaliteli Kazançlar: BIS yüksek kaliteli kazançlar sağlıyor.

Büyüyen Kar Marjı: BIS 'nin mevcut net kar marjları (2.6%) geçen yılın (2%) sinden daha yüksektir.

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: BIS şirketinin kazancı son 5 yılda yılda 0.8% oranında arttı.

Büyüme Hızlandırma: BIS 'un son bir yıldaki kazanç büyümesi ( 31.6% ) 5 yıllık ortalamasını (yıllık 0.8% ) aşıyor.

Kazançlar vs. Sektör: BIS geçen yılki kazanç büyümesi ( 31.6% ) Healthcare sektörünün 11.1% değerini aştı.

Özkaynak Getirisi

Yüksek ROE: BIS 'nin Özsermaye Getirisi ( 8.8% ) düşük olarak değerlendiriliyor.

Bioscience Animal Health Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 5/6

Anahtar bilgiler

Yakın geçmiş performans güncellemeleri

Third quarter 2024 earnings released: EPS: ฿0.055 (vs ฿0.053 in 3Q 2023)

Second quarter 2024 earnings released: EPS: ฿0.051 (vs ฿0.038 in 2Q 2023)

First quarter 2024 earnings released: EPS: ฿0.043 (vs ฿0.02 in 1Q 2023)

Full year 2023 earnings released: EPS: ฿0.16 (vs ฿0.20 in FY 2022)

Second quarter 2023 earnings released: EPS: ฿0.038 (vs ฿0.042 in 2Q 2022)

First quarter 2023 earnings released: EPS: ฿0.02 (vs ฿0.079 in 1Q 2022)

Recent updates

Third quarter 2024 earnings released: EPS: ฿0.055 (vs ฿0.053 in 3Q 2023)

Investor sentiment improves as stock rises 15%

Bioscience Animal Health Public Company Limited Announces Cash Dividend for the Operating Period from January 1, 2024 to June 30, 2024, Payable on September 11, 2024

First half dividend increased to ฿0.05

Second quarter 2024 earnings released: EPS: ฿0.051 (vs ฿0.038 in 2Q 2023)

Investor sentiment improves as stock rises 16%

First quarter 2024 earnings released: EPS: ฿0.043 (vs ฿0.02 in 1Q 2023)

Bioscience Animal Health Public Company Limited Approves the Remaining Dividend Payment from the Second Half Six-Month Operating Period 2023, Payable on May 21, 2024

Upcoming dividend of ฿0.07 per share

Bioscience Animal Health Public Company Limited, Annual General Meeting, Apr 24, 2024

Full year 2023 earnings released: EPS: ฿0.16 (vs ฿0.20 in FY 2022)

Final dividend increased to ฿0.07

Bioscience Animal Health Public Company Limited, Annual General Meeting, Apr 24, 2024

Insufficient new directors

Bioscience Animal Health Public Company Limited Announces Changing of Chief Accountant

New minor risk - Share price stability

Upcoming dividend of ฿0.04 per share at 1.9% yield

New major risk - Earnings quality

Second quarter 2023 earnings released: EPS: ฿0.038 (vs ฿0.042 in 2Q 2022)

Bioscience Animal Health Public Company Limited Announces Cash Dividend for the Period from January 1, 2023 to June 30, 2023, Payable on September 08, 2023

First quarter 2023 earnings released: EPS: ฿0.02 (vs ฿0.079 in 1Q 2022)

Upcoming dividend of ฿0.063 per share at 2.0% yield

Third quarter 2022 earnings released: EPS: ฿0.04 (vs ฿0.09 in 3Q 2021)

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS: ฿0.04 (vs ฿0.09 in 2Q 2021)

Bio Science Animal Health Public Company Limited Announces Cash Dividend for the Period from January 1, 2022 to June 30, 2022, Payable on September 09, 2022

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Bio Science Animal Health Public Company Limited has completed an IPO in the amount of THB 564 million.

Full year 2021 earnings released

Gelir ve Gider Dağılımı

Kazanç ve Gelir Geçmişi

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Özkaynak Getirisi

Varlık Getirisi

Kullanılan Sermaye Getirisi

Geçmişte güçlü performans gösteren şirketleri keşfedin